REG - Belluscura PLC - Statement re US Subsidiary Chapter 7 Update

BelluscuraAnnouncement

30/10/2025 10:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251030:nRSd5186Fa&default-theme=true

RNS Number : 5186F  Belluscura PLC  30 October 2025

 

29 October 2025

 

Belluscura plc

("Belluscura" or the "Company")

 

Belluscura LLC

 

Further to the notification of 28 October 2025, the Company confirms that
Belluscura LLC has today filed for Chapter 7 Bankruptcy under the U.S
Bankruptcy Code.

 

For further information please contact:

 

 Belluscura plc                                      Tel: +44 (0)20 3128 8100
 Paul Tuson, Chairman

                                                     Tel: +44 (0)20 3368 3550

 SPARK Advisory Partners Limited

 Nominated Adviser
 Neil Baldwin

                                                     Tel: +44 (0)20 3903 7715

 Dowgate Capital Limited

 Joint Broker
 Russell Cook / Daniel Ingram (Corporate Finance)

 Allenby Capital Ltd                                 Tel: +44 (0)20 3328 5656

 Joint Broker
 Amrit Nahal (Sales and Corporate Broking)

 Jeremy Porter / Lauren Wright (Corporate Finance)

                           Tel: +44 (0)20 3128 8100

                           email: Belluscura@mhpgroup.com (about:blank)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STRFZMFGGGVGKZM



            Copyright 2019 Regulatory News Service, all rights reserved